期刊文献+

霉酚酸酯联合强的松治疗乙肝病毒相关性肾炎 被引量:14

Study on Mycophenolate Mofetil Combined with Prednisone in Treating HBV-GN
下载PDF
导出
摘要 目的 :对比霉酚酸酯 (MMF)联合强的松与硫唑嘌呤联合强的松治疗乙肝病毒相关性肾炎 (HBV_GN)的疗效。方法 :A组服用MMF ,B组服用硫唑嘌呤。2组均服强的松。观察2组治疗有效率、乙型肝炎病毒复制指标、肝肾功能及治疗中的不良反应。结果 :2组肾组织中以HBsAg沉积为主 ;肾组织中乙肝病毒抗原成分与外周血不成比例 ;A组治疗后 ,尿蛋白排泄率显著降低 ,血清白蛋白水平明显升高(均P<0.05) ,而B组治疗前后两指标无显著性差异 ;治疗期间A组中有2例复发 ,重新治疗后均有效。结论 :MMF结合激素治疗HBV_GN有较明显的疗效 。 To compare the effects of treatment methods between Mycophenolate mofetil(MMF)and azathioprine(AZT)combined with prednisone respectively in treating HBV_GN.Methods:MMF was administered in group A,and AZT in group B.Prednisone was administered in both groups.The treatment effect rate,albuminuria amount,reproducing target of HVB(HbeAg,HBV_DNA),renal and liver function,and side effect were observed.Results:The main deposition in renal tissue was HBsAg.The depositions were out of proportion with component of HBV antigen in blood.After using MMF,the 24 hours albuminuria amount decreased significantly (P<0.05),and ALB increased significantly(P<0.05).Conclusion:MMF combined with prednisone to treat HBV_GN has an obvious effect compared with AZT combined with prednisone.MMF was safe and had fewer side effects in present dose with easily recurrence.
出处 《天津医药》 CAS 北大核心 2002年第12期730-732,共3页 Tianjin Medical Journal
关键词 霉酚酸酯 强的松 治疗 乙肝病毒相关性肾炎 泼尼松 mycophenolic acid prednisone hepatitis B virus nephritis
  • 相关文献

参考文献7

  • 1尚明花,徐培桢,徐琴君.霉酚酸酯治疗难治性肾病[J].上海医学,2000,23(2):122-124. 被引量:6
  • 2王海燕主编.乙型肝炎病毒相关性肾炎.肾脏病学.第2版.北京:人民卫生出版社,1996.1077-83.
  • 3王海燕 郑法雷 等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,2:131-134.
  • 4Combes B, Stastny P. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet, 1971,2: 234~ 6.
  • 5陈国柱,章友康,邹万忠,鄂洁,王海燕.乙型肝炎病毒在成人膜性肾病中的致病作用[J].中华医学杂志,1995,75(9):540-542. 被引量:23
  • 6沈雯,陆福明,张秀荣,杨海春,林善锬,郭慕依.乙型肝炎病毒感染与肾小球肾炎[J].中华肾脏病杂志,1999,15(3):177-180. 被引量:38
  • 7Lai CL, Liaw YF, Lewns NW, et al. Genotypic resistance to lamivudine in a prospective, place-controlled multicentre study in Asia of Lamivudine therapy for chronic hepatitis B infection:incidence, kineties of emergence, and correlation with disease parameters. Hepatology, 1997, 2654: 259~60.

二级参考文献20

  • 1张月娥 郭慕依 等.乙型肝炎病毒免疫复合物肾小球肾炎的免疫病理的进一步研究[J].中华内科杂志,1990,29:526-529.
  • 21,Sollinger HW. Update on preclinical and clinical experience with mycop henolate mofetil. Transplantation Proceedings 1996,29 Suppl 1:24-29.
  • 32,Groth CG. For the European MMF cooperative study group. The European e xperience with mycophenolate mofetil. Transplantation Proceedings 1996,28 Suppl 1:30-33.
  • 45,Corna D, Morigi M, Facchinetti D, et al. Mycophenolate myfetil limit r enal damage and prolongs life in murin lupis autoimmune disease. Kidney Int 1997 ,51:1589-1589..
  • 56,Willam A. Briggs, Michael J. Chor, Paul J. Scheel, Jr Successful mycop henolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998,31:213-2 17.
  • 6肖桂兰,中华病理学杂志,1993年,22卷,361页
  • 7张景红,中华内科杂志,1990年,29卷,534页
  • 8张月娥,中华内科杂志,1990年,29卷,526页
  • 9马学玲,中华病理学杂志,1998年,27卷,269页
  • 10汪年松,中华肾脏病杂志,1998年,14卷,167页

共引文献738

同被引文献165

引证文献14

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部